Escalon Medical (ESMC) Stock Price
Escalon Medical Price
Revenue at Escalon Medical has contracted by 4.7% per year over the past 19 years to 12.05 M USD. Escalon Medical's net margin stands at 0.9%, up from -0.5% several years earlier. The stock trades about 52% above its 52-week low.
Escalon Medical stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Escalon Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Escalon Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Escalon Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Escalon Medical Price |
|---|---|
| 8/21/2026 | 0.18 USD |
| 8/20/2026 | 0.18 USD |
| 8/19/2026 | 0.17 USD |
| 8/18/2026 | 0.17 USD |
| 8/17/2026 | 0.20 USD |
| 8/14/2026 | 0.20 USD |
| 8/13/2026 | 0.17 USD |
| 8/12/2026 | 0.17 USD |
| 8/11/2026 | 0.18 USD |
| 8/10/2026 | 0.19 USD |
| 8/7/2026 | 0.19 USD |
| 8/6/2026 | 0.19 USD |
| 8/5/2026 | 0.19 USD |
| 8/4/2026 | 0.19 USD |
| 8/3/2026 | 0.19 USD |
| 7/31/2026 | 0.19 USD |
| 7/30/2026 | 0.18 USD |
| 7/29/2026 | 0.18 USD |
| 7/27/2026 | 0.20 USD |
| 7/23/2026 | 0.20 USD |
| 7/22/2026 | 0.20 USD |
| 7/21/2026 | 0.20 USD |
| 7/20/2026 | 0.20 USD |
| 7/17/2026 | 0.20 USD |
| 7/16/2026 | 0.18 USD |
| 7/15/2026 | 0.18 USD |
| 7/14/2026 | 0.19 USD |
| 7/13/2026 | 0.19 USD |
| 7/10/2026 | 0.19 USD |
| 7/9/2026 | 0.19 USD |
| 7/8/2026 | 0.19 USD |
| 7/7/2026 | 0.19 USD |
| 7/6/2026 | 0.19 USD |
| 7/2/2026 | 0.19 USD |
| 7/1/2026 | 0.19 USD |
| 6/30/2026 | 0.20 USD |
| 6/29/2026 | 0.19 USD |
| 6/26/2026 | 0.18 USD |
| 6/25/2026 | 0.18 USD |
| 6/24/2026 | 0.18 USD |
| 6/23/2026 | 0.18 USD |
| 6/22/2026 | 0.18 USD |
| 6/18/2026 | 0.18 USD |
| 6/17/2026 | 0.20 USD |
| 6/16/2026 | 0.20 USD |
| 6/15/2026 | 0.20 USD |
| 6/12/2026 | 0.20 USD |
| 6/11/2026 | 0.20 USD |
| 6/10/2026 | 0.19 USD |
| 6/9/2026 | 0.19 USD |
| 6/8/2026 | 0.19 USD |
| 6/5/2026 | 0.19 USD |
| 6/4/2026 | 0.21 USD |
| 6/3/2026 | 0.21 USD |
| 6/2/2026 | 0.20 USD |
| 6/1/2026 | 0.20 USD |
| 5/29/2026 | 0.20 USD |
| 5/28/2026 | 0.21 USD |
| 5/27/2026 | 0.19 USD |
| 5/26/2026 | 0.21 USD |
| 5/22/2026 | 0.21 USD |
| 5/21/2026 | 0.21 USD |
| 5/20/2026 | 0.21 USD |
| 5/19/2026 | 0.23 USD |
| 5/18/2026 | 0.25 USD |
| 5/15/2026 | 0.25 USD |
| 5/14/2026 | 0.26 USD |
| 5/13/2026 | 0.26 USD |
| 5/12/2026 | 0.17 USD |
| 5/11/2026 | 0.17 USD |
| 5/8/2026 | 0.17 USD |
| 5/7/2026 | 0.17 USD |
| 5/6/2026 | 0.17 USD |
| 5/5/2026 | 0.17 USD |
| 5/4/2026 | 0.17 USD |
| 5/1/2026 | 0.17 USD |
| 4/30/2026 | 0.17 USD |
| 4/28/2026 | 0.17 USD |
| 4/21/2026 | 0.17 USD |
| 4/16/2026 | 0.17 USD |
| 4/15/2026 | 0.17 USD |
| 4/14/2026 | 0.21 USD |
| 4/2/2026 | 0.16 USD |
| 4/1/2026 | 0.14 USD |
| 3/31/2026 | 0.18 USD |
| 3/27/2026 | 0.16 USD |
| 3/26/2026 | 0.20 USD |
| 3/18/2026 | 0.19 USD |
| 3/17/2026 | 0.21 USD |
| 3/16/2026 | 0.20 USD |
| 3/9/2026 | 0.25 USD |
| 3/6/2026 | 0.23 USD |
| 3/4/2026 | 0.23 USD |
| 3/3/2026 | 0.21 USD |
| 3/2/2026 | 0.25 USD |
| 2/27/2026 | 0.25 USD |
| 2/26/2026 | 0.24 USD |
| 2/23/2026 | 0.25 USD |
| 2/19/2026 | 0.21 USD |
| 2/17/2026 | 0.17 USD |
| 2/13/2026 | 0.19 USD |
| 2/12/2026 | 0.19 USD |
| 2/11/2026 | 0.17 USD |
| 2/10/2026 | 0.19 USD |
| 2/4/2026 | 0.18 USD |
| 2/3/2026 | 0.18 USD |
| 2/2/2026 | 0.18 USD |
| 1/30/2026 | 0.17 USD |
| 1/29/2026 | 0.16 USD |
| 1/28/2026 | 0.16 USD |
| 1/27/2026 | 0.16 USD |
| 1/23/2026 | 0.16 USD |
| 1/6/2026 | 0.16 USD |
| 12/31/2025 | 0.17 USD |
| 12/30/2025 | 0.17 USD |
| 12/19/2025 | 0.17 USD |
| 12/18/2025 | 0.15 USD |
| 12/17/2025 | 0.15 USD |
| 12/15/2025 | 0.14 USD |
| 12/12/2025 | 0.14 USD |
| 12/1/2025 | 0.16 USD |
| 11/28/2025 | 0.17 USD |
| 11/26/2025 | 0.17 USD |
| 11/21/2025 | 0.16 USD |
| 11/20/2025 | 0.16 USD |
| 11/14/2025 | 0.17 USD |
| 11/13/2025 | 0.17 USD |
| 11/10/2025 | 0.16 USD |
| 11/7/2025 | 0.16 USD |
| 11/4/2025 | 0.16 USD |
| 11/3/2025 | 0.15 USD |
| 10/31/2025 | 0.16 USD |
| 10/30/2025 | 0.16 USD |
| 10/27/2025 | 0.15 USD |
| 10/24/2025 | 0.16 USD |
| 10/23/2025 | 0.16 USD |
| 10/22/2025 | 0.18 USD |
| 10/17/2025 | 0.18 USD |
| 10/16/2025 | 0.16 USD |
| 10/15/2025 | 0.16 USD |
| 10/14/2025 | 0.16 USD |
| 10/9/2025 | 0.16 USD |
| 10/8/2025 | 0.16 USD |
| 10/7/2025 | 0.15 USD |
| 10/6/2025 | 0.15 USD |
| 10/3/2025 | 0.15 USD |
| 10/2/2025 | 0.14 USD |
| 10/1/2025 | 0.12 USD |
| 9/30/2025 | 0.17 USD |
| 9/25/2025 | 0.17 USD |
| 9/24/2025 | 0.19 USD |
| 9/19/2025 | 0.14 USD |
| 9/18/2025 | 0.14 USD |
| 9/17/2025 | 0.18 USD |
| 9/16/2025 | 0.12 USD |
| 9/15/2025 | 0.18 USD |
| 9/12/2025 | 0.19 USD |
| 9/11/2025 | 0.19 USD |
| 9/9/2025 | 0.17 USD |
| 9/8/2025 | 0.15 USD |
| 9/5/2025 | 0.17 USD |
| 9/4/2025 | 0.17 USD |
| 8/28/2025 | 0.15 USD |
| 8/27/2025 | 0.16 USD |
Escalon Medical Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Escalon Medical Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.00 | 29.00 | 24.00 | 11.00 | 12.00 | 13.00 | 11.00 | 11.00 | 11.00 | 9.00 | 9.00 | 10.00 | 10.00 | 12.00 | 11.00 | 12.00 |
| -8.82 | -6.45 | -17.24 | -54.17 | 9.09 | 8.33 | -15.38 | – | – | -18.18 | – | 11.11 | – | 20.00 | -8.33 | 9.09 |
| 48.39 | 44.83 | 37.50 | 45.45 | 50.00 | 46.15 | 45.45 | 45.45 | 45.45 | -44.44 | 44.44 | 40.00 | 40.00 | 41.67 | 45.45 | 41.67 |
| 15.00 | 13.00 | 9.00 | 5.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | -4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 |
| – | – | -2.00 | -1.00 | – | -1.00 | -1.00 | – | – | – | – | – | – | – | – | – |
| – | – | -8.33 | -9.09 | – | -7.69 | -9.09 | – | – | – | – | – | – | – | – | – |
| – | – | -5.00 | 2.00 | – | – | -1.00 | – | – | – | – | – | – | – | – | – |
| – | – | – | -140.00 | – | – | – | – | – | – | – | – | – | – | – | – |
| 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Escalon Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Escalon Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Escalon Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Escalon Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Escalon Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Escalon Medical stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Escalon Medical Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Escalon Medical business model & stock analysis
Escalon Medical SWOT Analysis
Strengths
Escalon Medical Corp has several strengths that contribute to its competitive advantage in the market. These include:
- Strong product portfolio: Escalon offers a diverse range of medical products, including ophthalmic diagnostic instruments, surgical devices, and pharmaceuticals.
- Established market presence: The company has a long-standing presence in the medical industry, with a well-known brand and a loyal customer base.
- Research and development capabilities: Escalon invests in ongoing research and development to innovate and improve its product offerings, staying ahead of competitors.
- Effective distribution network: The company has a wide network of distributors and partners, enabling efficient product delivery and market reach.
Weaknesses
Despite its strengths, Escalon Medical Corp also faces certain weaknesses, which it should address to remain competitive:
- Dependency on a limited number of customers: Escalon relies heavily on a few key customers for a significant portion of its revenue, creating vulnerability to their decisions and market conditions.
- Relatively small market share: The company operates in a highly competitive industry, and its market share is relatively smaller compared to some of its larger competitors.
- Limited geographical presence: Escalon's operations are primarily focused in certain regions, limiting its exposure to potential markets and growth opportunities.
- Dependency on key suppliers: The company relies on specific suppliers for critical components, which may lead to supply chain disruptions or increased costs if alternatives are not readily available.
Opportunities
Escalon Medical Corp can leverage the following opportunities to expand and enhance its business:
- Increasing demand for advanced medical technologies: The rising need for efficient diagnostic and surgical instruments presents opportunities for Escalon to develop and market innovative products.
- Expanding into emerging markets: There is potential for the company to enter new geographic markets with growing healthcare infrastructure and demand.
- Strategic partnerships and acquisitions: Collaborating with other companies or acquiring complementary businesses can help Escalon broaden its product portfolio and market reach.
- Focus on telehealth and remote monitoring: With the increasing adoption of telehealth solutions, Escalon can develop solutions to meet the evolving needs of healthcare providers and patients.
Threats
Escalon Medical Corp should be aware of the following threats, which could impact its performance and market position:
- Intense competition: The medical industry is highly competitive, with numerous established players and new entrants, which can potentially erode Escalon's market share.
- Changing regulatory environment: Evolving regulations and policies in the healthcare sector may introduce compliance challenges and affect the availability or reimbursement of certain products.
- Economic downturns: During economic downturns, reduced healthcare spending and budget constraints can impact Escalon's sales and profitability.
- Technological advancements: Rapid technological advancements in the medical field may render certain products or technologies obsolete, requiring continuous innovation and adaptation.
Escalon Medical Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Escalon Medical Segments
Escalon Medical Revenue by Segment
3 Years
5 Years
10 Years
Max
Details
Escalon Medical Revenue by Region
3 Years
5 Years
Max
Details
Escalon Medical Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Escalon Medical historical P/E ratio, EBIT multiple, and P/S ratio
Escalon Medical annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Escalon Medical shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Escalon Medical stock splits
Escalon Medical Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 2/14/2006 | -0.02USD | - | 7.59 MUSD | - | 2006 Q2 |
| 11/14/2005 | 0.11USD | - | 7.26 MUSD | - | 2006 Q1 |
| 9/29/2005 | 0.12USD | - | 7.99 MUSD | - | 2005 Q4 |
| 5/16/2005 | -0.04USD | - | 6.68 MUSD | - | 2005 Q3 |
Escalon Medical shareholder structure
| % | Name |
|---|---|
0.98815% | |
0.00175% | |
0.00000% |
Escalon Medical Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
9.99% | SEC ↗ | |
9.10% | SEC ↗ | |
7.90% | SEC ↗ | |
6.24% | SEC ↗ | |
6.24% | SEC ↗ | |
5.70% | SEC ↗ | |
5.70% | SEC ↗ | |
4.11% | SEC ↗ | |
4.11% | SEC ↗ | |
4.11% | SEC ↗ |
Escalon Medical Executives and Management Board
8 members · avg. age 54 · 13 % women
Richard DePiano (47)
President, Chief Executive Officer, General Counsel, Director · since 2006
224,600.00 USD
Management
Mr. Mark Wallace (44)
Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer
Board of Directors
Mr. Richard DePiano (73)
Chairman of the Board · since 1996
Mr. John Dogum
Director
Mr. David Jacovini (42)
Director
Mr. C. Todd Trusk
Director
Mr. Fred Choate (69)
Independent Director
Ms. Lisa Napolitano (48)
Independent Director
Escalon Medical Supply Chain
Escalon Medical Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.68 | 0.56 | — | ||
| 2 | -0.08 | -0.47 | — |
Frequently asked questions about Escalon Medical
The business model of Escalon Medical Corp is focused on innovative medical devices and pharmaceutical products. The company aims to address unmet medical needs and improve patient outcomes through its product portfolio. Escalon Medical Corp specializes in ophthalmology, offering diagnostic and surgical equipment along with pharmaceuticals for conditions such as glaucoma and diabetic retinopathy. The company's commitment to cutting-edge technologies and a strong presence in the ophthalmic market enables it to provide effective solutions for eye care professionals and patients worldwide. With a comprehensive range of products tailored to meet specific needs, Escalon Medical Corp continues to drive advancements in the field of ophthalmology.
Escalon Medical Corp is primarily active in the medical device industry.
The main competitors of Escalon Medical Corp in the market include companies such as Becton, Dickinson and Company (BD), Johnson & Johnson, Thermo Fisher Scientific, Siemens Healthineers, and Medtronic.
Escalon Medical Corp is a renowned company that specializes in the development and marketing of medical devices for eye care. Founded in 1987, Escalon Medical Corp has a rich history and extensive expertise in ophthalmic diagnostics and surgical products. With a strong focus on innovation and customer satisfaction, the company has built a solid reputation for providing cutting-edge technologies to healthcare professionals worldwide. Escalon Medical Corp's dedication to improving vision care has made it a trusted name in the industry. Over the years, the company's commitment to quality and advancement has contributed to its continued success and growth in the medical technology sector.
Escalon Medical Corp has achieved several significant milestones throughout its history. Some notable achievements include expanding its product portfolio with innovative and high-quality medical devices, establishing a strong presence in the ophthalmic diagnostic imaging market, and successfully launching advanced diagnostic tools. Additionally, the company has demonstrated consistent growth and profitability, earning a reputation for its commitment to delivering cutting-edge healthcare solutions. Escalon Medical Corp has also made substantial investments in research and development, further enhancing its capabilities and staying ahead of industry trends. These accomplishments highlight the company's dedication to advancing healthcare and position it as a trusted leader in the medical device sector.
Escalon Medical Corp is primarily present in the United States.
Escalon Medical Corp represents a commitment to providing innovative and high-quality medical devices and pharmaceuticals. With an emphasis on improving patient care, the company focuses on developing and commercializing products for ophthalmology and other medical specialties. Escalon Medical Corp strives to meet the evolving needs of healthcare professionals by delivering advanced technologies and solutions that enhance diagnostic capabilities and treatment outcomes. The company's corporate philosophy centers around integrity, collaboration, and customer satisfaction, aiming to establish enduring partnerships and foster growth within the healthcare industry.
Converted at the current exchange rate, the Escalon Medical share trades at 0.15 EUR (0.18 USD).
Escalon Medical Corp is an innovative company in the field of medical devices that specializes in the development, manufacturing, and marketing of advanced technologies. The company was founded in 1987 and is headquartered in Wayne, Pennsylvania. Escalon Medical Corp's business model focuses on three main segments: ophthalmic instruments, diagnostic devices, and medical disposables. In the ophthalmic segment, the company offers a wide range of instruments and accessories used by ophthalmologists worldwide. These instruments include eye surgical scissors, forceps, needles, and other tools. Key products in this area also include ultrasound and laser systems for the diagnosis and treatment of retinal diseases such as macular degeneration. In the diagnostic devices segment, Escalon Medical Corp manufactures equipment used by doctors and clinics for disease diagnosis. These devices include retina scanners, tonometers, ultrasound devices, and other highly precise instruments. These diagnostic systems are capable of providing detailed images of the eye or retina, enabling the treating physician to make accurate assessments of the patient's condition and ensure appropriate treatment. The company's medical disposables can be used in medical laboratories and clinical practice. These include a range of blood lancets, syringes, medical tubing, infusion bags, and other single-use devices. These products are important for ensuring optimal hygiene in medical facilities. In terms of marketing, the company focuses on various strategies. For example, it has established a network of distribution partners to bring a broad range of products to the market. Additionally, the company also collaborates closely with key organizations such as the American Optometric Association or the Association for Research in Vision and Ophthalmology. Escalon Medical Corp also works on selling its products directly to clinics, hospitals, and medical practices. The company's business model is based on the development and provision of high-quality medical instruments and accessories. It is constantly striving to improve its production processes and technologies to enhance its competitiveness in the market. In summary, Escalon Medical Corp's business model offers a wide range of products and services in the field of ophthalmic instruments, diagnostic devices, and medical disposables. The company pursues a clear and comprehensive strategy to bring its products to the market directly and indirectly, while always increasing its high quality, customer focus, and innovation capability.
The revenue cannot currently be calculated for Escalon Medical.
The profit cannot currently be calculated for Escalon Medical.
The P/E ratio cannot be calculated for Escalon Medical at the moment.
The P/S cannot be calculated for Escalon Medical currently.
The Eulerpool Quality Score for Escalon Medical is 3/10.
The ISIN of Escalon Medical is US2960743050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Escalon Medical is 884822. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Escalon Medical is ESMC. The ticker symbol is used to trade Escalon Medical shares on the stock exchange.
Escalon Medical paid dividends every year for the past 0 years.
Escalon Medical is assigned to the 'Health' sector.
The dividends of Escalon Medical are distributed in USD.
Escalon Medical stock
Escalon Medical Peer Group
Escalon Medical Ticker
Escalon Medical FIGI
All fundamentals and in-depth analysis of Escalon Medical
Our stock analysis for Escalon Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Escalon Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.